Twilight in the emergency department: Porphyria, mad kings, vampires and werewolves? A brief review

Anderson, K.E., Bloomer, J.R., Bonkovsky, H.L., Kushner, J.P., Pierach, C.A., Pimstone, N.R., et al. (2005). Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med, 2005, 142(6), 439–50.

Anderson, K.E., & Collins, S. (2006). Open-label study of hemin for acute porphyria: Clinical practice implications. Am J Med, 119(9), 801.e19–24.

Anderson, K.E., Sassa, S., Bishop, D.F., & Desnick, R.J. (2001). Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In, C.R. Scriver, A.L. Beaudet, W.S. Sly, et al. (Eds.), Metabolic and Molecular Basis of Inherited Disease (pp. 2991–3062). New York, NY: McGraw Hill.

Beveridge, A. (2003). The madness of politics. J R Soc Med, 96(12), 602–4.

Burry, J.N., & Lawrence, J.R. (1976). Phototoxic blisters from high frusemide dosage. Br J Dermatol, 94(5), 495–9.

Bylesjo, I., Forsgren, L., Lithner, F., & Boman, K. (1996). Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia, 37(3), 230–5.

Bylesjo, I., Wikberg, A., & Andersson, C. (2009). Clinical aspects of acute intermittent porphyria in northern Sweden: A population-based study. Scand J Clin Lab Invest, 69(5), 612–8.

Canavese, C., Gabrielli, D., Guida, C., & Cappellini, M.D. (2002). Nephrologists and porphyrias. G Ital Nefrol., 19(4), 393–412.

Champe, P.C., & Harvey, R.A. (Eds.). (1994). Conversion of amino acids to specialized products. Biochemistry (2nd ed., pp. 260–1). Philadelphia, PA: Lippincott, Williams & Wilkins.

Cooper, J., & Powell, A.S. (2006). King George’s illness—porphyria. Retrieved from http://people.virginia.edu/~jlc5f/charlotte/porphyria.html

Doss, M.O., Stauch, T., Gross, U., Renz, M., Akagi, R., Doss-Frank, M., et al. (2004). The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany. J Inherit Metab Dis., 27(4), 529–36.

Elder, G.H., Smith, S.G., & Smyth, S.J. (1990). Laboratory investigation of the porphyrias. Ann Clin Biochem., 27(Pt 5), 395–412.

Ellencweig, N., Schoenfeld, N., & Zemishlany, Z. (2006). Acute intermittent porphyria: Psychosis as the only clinical manifestation. Isr J Psychiatry Relat Sci., 43(1), 52–6.

European Porphyria Initiative. Retrieved February 25, 2010, from www.porphyria-europe.com

Forbes, C.D., & Jackson, W.F. (Eds.). (1997). Endocrine, metabolic and nutritional. ColorAtlas and Text of Clinical Medicine (2nd ed., p. 349). Barcelona, Spain: Times Mirror International / Mosby.

Gorchein, A. (1997). Drug treatment in acute porphyria. Br J Clin Pharmacol., 44(5), 427–34.

Kauppinen, R. (2005). Porphyrias. Lancet, 365(9455), 241–52.

Kirsch, R.E., Meissner, P.N., & Hift, R.J. (1998). Variegate porphyria. Semin Liver Dis., 18(1), 33–41.

Lane, N. (2002, December 16). Born to the purple: The story of porphyria. Scientific American.

Li, D. (2005). PGC-1alpha: Looking behind the sweet treat for porphyria. Cell, 122(4), 487–9.

Liu, Y.P., Lien, W.C., Fang, C.C., Lai, T.I., Chen, W.J., & Wang, H.P. (2005). ED presentation of acute porphyria. Am J Emerg Med, 23(2), 164–7.

Loftus, L.S., & Arnold, W.N. (1991). Vincent van Gogh’s illness: Acute intermittent porphyria? BMJ, 303(6817), 1589–91.

Macalpine, I., & Hunter, R. (1966). The “insanity” of King George 3rd: A classic case of porphyria. Br Med J, 1(5479), 65–71.

Macalpine, I., Hunter, R., & Rimington, C. (1968). Porphyria in the royal houses of Stuart, Hanover, and Prussia. A follow-up study of George 3rd’s illness. Br Med J, 1(5583), 7–18.

Millward, L.M., Kelly, P., King, A., & Peters, T.J. (2005). Anxiety and depression in the acute porphyrias. J Inherit Metab Dis, 28(6), 1099–107.

Neuromuscular Disease Center. Washington University, St. Louis, MO. http://neuromuscular.wustl.edu/

“Nosferatu—A Filmarcheology”, ChiaroScuro/CeltoSlavica (Markus Osterrieder). http://www.celtoslavica.de/chiaroscuro/vergleiche/nos.html

Poh-Fitzpatrick, M.B., Honig, P.J., Kim, H.C., & Sassa, S. (1992). Childhood-onset familial porphyria cutanea tarda: Effects of therapeutic phlebotomy. J Am Acad Dermatol, 27(5 Pt 2), 896–900.

Sadeh, M., Blatt, I., Martonovits, G., Karni, A., & Goldhammer, Y. (1991). Treatment of porphyric convulsions with magnesium sulfate. Epilepsia, 32(5), 712–5.

Stenberg, A. (1990). Pseudoporphyria and sunbeds. Acta Derm Venereol, 70(4), 354–6.

Tasnadi, G., Bor, M., Pusztai, A., & Szekely, E. (2003). Acute porphyrias in differential diagnosis [Hungarian]. Orv Hetil., 144(17), 811–8.

Thadani, H., Deacon, A., & Peters, T. (2000). Diagnosis and management of porphyria. BMJ, 320(7250), 1647–1651.

Tobe, B.A. (n.d.). A guide to porphyria. Canadian Association for Porphyria.

Tolland, J.P., McKeown, P.P., & Corbett, J.R. (2007). Voriconazole-induced pseudoporphyria. Photodermatol Photoimmunol Photomed, 23(1), 29–31.

Zelickson, A.S. (1964). Phototoxic reaction with nalidixic acid. JAMA, 190, 556–7.